Genotype-based prevention of psychosis onset and schizophrenia: A personalized approach in a target population

Bahar Taneri, Mevhibe B. Hocaoglu, Angela Brand, Jim Van Os

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Schizophrenia imposes a significant burden on public health, affecting approximately 25 million individuals worldwide and generating an extensive healthcare burden. It is important to consider that the disease onset in schizophrenia stems from gene-environment interactions. Early interventions in order to prevent schizophrenia are of high clinical interest, and this is where personalized healthcare and medicine comes in. In this article, we bring a genotype-based personalized, preventive perspective to psychosis onset and schizophrenia. Our objective relies on the possibility of making use of a specific gene-environment interaction in the emergence of schizophrenia as a personalized preventive tool. In particular, we discuss screening of a specific AKT1 allelic variation and its interaction with cannabis use as a preventive approach in a target population with early symptoms of psychosis.

Original languageEnglish
Pages (from-to)167-172
Number of pages6
JournalPersonalized Medicine
Volume11
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Health Services Needs and Demand
Psychotic Disorders
Schizophrenia
Genotype
Gene-Environment Interaction
Delivery of Health Care
Precision Medicine
Cannabis
Public Health

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Molecular Medicine
  • Pharmacology

Cite this

@article{a40aaa725ccf4b4392c7cf2121b7d023,
title = "Genotype-based prevention of psychosis onset and schizophrenia: A personalized approach in a target population",
abstract = "Schizophrenia imposes a significant burden on public health, affecting approximately 25 million individuals worldwide and generating an extensive healthcare burden. It is important to consider that the disease onset in schizophrenia stems from gene-environment interactions. Early interventions in order to prevent schizophrenia are of high clinical interest, and this is where personalized healthcare and medicine comes in. In this article, we bring a genotype-based personalized, preventive perspective to psychosis onset and schizophrenia. Our objective relies on the possibility of making use of a specific gene-environment interaction in the emergence of schizophrenia as a personalized preventive tool. In particular, we discuss screening of a specific AKT1 allelic variation and its interaction with cannabis use as a preventive approach in a target population with early symptoms of psychosis.",
author = "Bahar Taneri and Hocaoglu, {Mevhibe B.} and Angela Brand and {Van Os}, Jim",
year = "2014",
doi = "10.2217/pme.13.103",
language = "English",
volume = "11",
pages = "167--172",
journal = "Personalized Medicine",
issn = "1741-0541",
publisher = "Future Medicine Ltd.",
number = "2",

}

Genotype-based prevention of psychosis onset and schizophrenia : A personalized approach in a target population. / Taneri, Bahar; Hocaoglu, Mevhibe B.; Brand, Angela; Van Os, Jim.

In: Personalized Medicine, Vol. 11, No. 2, 2014, p. 167-172.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genotype-based prevention of psychosis onset and schizophrenia

T2 - A personalized approach in a target population

AU - Taneri, Bahar

AU - Hocaoglu, Mevhibe B.

AU - Brand, Angela

AU - Van Os, Jim

PY - 2014

Y1 - 2014

N2 - Schizophrenia imposes a significant burden on public health, affecting approximately 25 million individuals worldwide and generating an extensive healthcare burden. It is important to consider that the disease onset in schizophrenia stems from gene-environment interactions. Early interventions in order to prevent schizophrenia are of high clinical interest, and this is where personalized healthcare and medicine comes in. In this article, we bring a genotype-based personalized, preventive perspective to psychosis onset and schizophrenia. Our objective relies on the possibility of making use of a specific gene-environment interaction in the emergence of schizophrenia as a personalized preventive tool. In particular, we discuss screening of a specific AKT1 allelic variation and its interaction with cannabis use as a preventive approach in a target population with early symptoms of psychosis.

AB - Schizophrenia imposes a significant burden on public health, affecting approximately 25 million individuals worldwide and generating an extensive healthcare burden. It is important to consider that the disease onset in schizophrenia stems from gene-environment interactions. Early interventions in order to prevent schizophrenia are of high clinical interest, and this is where personalized healthcare and medicine comes in. In this article, we bring a genotype-based personalized, preventive perspective to psychosis onset and schizophrenia. Our objective relies on the possibility of making use of a specific gene-environment interaction in the emergence of schizophrenia as a personalized preventive tool. In particular, we discuss screening of a specific AKT1 allelic variation and its interaction with cannabis use as a preventive approach in a target population with early symptoms of psychosis.

UR - http://www.scopus.com/inward/record.url?scp=84899480509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899480509&partnerID=8YFLogxK

U2 - 10.2217/pme.13.103

DO - 10.2217/pme.13.103

M3 - Article

AN - SCOPUS:84899480509

VL - 11

SP - 167

EP - 172

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 2

ER -